Data as of Q4 2025 (Dec 31, 2025)

LifeMD, Inc.

(LFMD)

Financial Statements · SEC EDGAR XBRL

Net Income
-$11.2M
-145.9%
EPS
$0.25
+141.7%
Op. Income
-$7.7M
+62.4%
FCF
$6.4M
-60.1%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$27.7M
$21.4M
$18.9M
$18.7M
$18.0M
$166.3M
$133.4M
$133.6M
$100.4M
$74.9M
$174.0M
$153.8M
$148.1M
$143.8M
$129.2M
-$7.7M
-$20.4M
-$14.5M
-$43.4M
-$54.3M
$1.4M
$2.2M
$2.6M
$1.3M
$3.0M
-$10.2M
-$22.6M
-$17.4M
-$44.7M
-$61.3M
$46K
$598K
$428K
$361K
$8K
-$11.2M
$24.5M
$17.8M
-$45.5M
-$60.9M
$0.25
$-0.60
-
-
-
$0.25
$-0.60
-
-
-
45.1M
41.2M
33.9M
31.0M
27.0M